Onartuzumab (MetMAb): Using Nonclinical Pharmacokinetic and Concentration–Effect Data to Support Clinical Development
暂无分享,去创建一个
M. Merchant | N. Jumbe | I. Nijem | Judy C. Young | A. Peterson | B. Bender | H. Xiang | L. Damico-Beyer | A. Reyes | E. Mai | M. Romero | T. Davancaze | Elaine Mai | Teresa Davancaze | Ihsan Nijem